[{"id":"ff8e88df-126d-488f-a48d-40c230f71a19","acronym":"","url":"https://clinicaltrials.gov/study/NCT02884726","created_at":"2021-01-29T07:13:06.696Z","updated_at":"2024-07-02T16:36:47.958Z","phase":"Phase 1","brief_title":"Phase 1 Study of Mesothelin-ADC","source_id_and_acronym":"NCT02884726","lead_sponsor":"Bristol-Myers Squibb","biomarkers":" MSLN","pipe":" | ","alterations":" MSLN expression","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BMS-986148"],"overall_status":"Completed","enrollment":" Enrollment 8","initiation":"Initiation: 10/14/2016","start_date":" 10/14/2016","primary_txt":" Primary completion: 09/06/2017","primary_completion_date":" 09/06/2017","study_txt":" Completion: 09/06/2017","study_completion_date":" 09/06/2017","last_update_posted":"2020-03-19"}]